Open AccessTreatment With Once-Weekly Alendronate 70 mg Compared With Once-Weekly Risedronate 35 mg in Women With Postmenopausal Osteoporosis: A Randomized Double-Blind Study
Author(s) -
Clifford J. Rosen,
Marc C. Hochberg,
Sydney Lou Bonnick,
Michael R. McClung,
Paul D. Miller,
Susan B. Broy,
Risa Kagan,
Erluo Chen,
Richard A. Petruschke,
Desmond Thompson,
Anne E. de Papp,
for the Fosamax Actonel Comparison Investigators
Publication year - 2005
Publication title -
journal of bone and mineral research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.882
H-Index - 241
eISSN - 1523-4681
pISSN - 0884-0431
DOI - 10.1359/jbmr.2005.20.1.141
Subject(s) - medicine , etidronic acid , osteoporosis , postmenopausal women , alendronic acid , double blind , randomized controlled trial , postmenopausal osteoporosis , bone density conservation agents , urology , bone mineral , placebo , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom